Trigger Point Dry Needling 2013
DOI: 10.1016/b978-0-7020-4601-8.00004-9
|View full text |Cite
|
Sign up to set email alerts
|

Trigger point dry needling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…These alarming global prevalence rates translate into an increased likelihood of infection with up to twenty blood-borne pathogens, including hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) [4][5][6][7]. The infectivity of these pathogens is estimated to be as low as 0.3% for HIV, to 3% for HCV, and as high as 30% for HBV [8]. With the infectivity rate of the aforementioned blood-borne pathogens associated with PEIs combined with the high prevalence of percutaneous exposure globally, one is tempted to imagine what factors might contribute to the occurrence of these incidents.…”
Section: Introductionmentioning
confidence: 99%
“…These alarming global prevalence rates translate into an increased likelihood of infection with up to twenty blood-borne pathogens, including hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) [4][5][6][7]. The infectivity of these pathogens is estimated to be as low as 0.3% for HIV, to 3% for HCV, and as high as 30% for HBV [8]. With the infectivity rate of the aforementioned blood-borne pathogens associated with PEIs combined with the high prevalence of percutaneous exposure globally, one is tempted to imagine what factors might contribute to the occurrence of these incidents.…”
Section: Introductionmentioning
confidence: 99%